Chantal Pelletier of Grand Falls, N.B. is sharing what her life is like wearing a left ventricular assist device (LVAD), a ...

Inter-atrial shunt device therapy has shown mixed results in clinical trials, with clinical 'non-responders' typically showing features of more advanced heart failure. We aimed to analyse the ...

Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that ...

Milestone Pharmaceuticals Inc.’s MIST share price has surged by 11.06%, which has investors questioning if this is right time to sell.

One young girl is about to spend her third consecutive birthday at Primary Children’s Hospital. Sienna, 4, was born with hypoplastic left heart syndrome and needs an artificial heart and a medical ...

In October 2010, Destany Epps-Manuel was only 22 years old when she was suddenly diagnosed with idiopathic dilated cardiomyopathy, a heart dise ...

Pulmonary hypertension (PH) risk grows over time for patients with narrowing of the aorta, the body's biggest blood vessel, ...

Whenever I hear or read a message from a company that wants to do business with me telling me that they take the privacy of my health information very seriously, ...

Inhibrx Biosciences, Inc. ("Inhibrx" or the "Company") today reported financial results for the fourth quarter and fiscal year 2024. Following the completion of the sale of INBRX-101 by Inhibrx, Inc.